Quinolone-based compounds with anticancer activity
US10981875B2 · kind B2 · utility
0Cited by
1References
20Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Dec 8, 2017 |
| Grant date | Apr 20, 2021 |
| Priority date | — |
| Expiry date | Dec 8, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Embodiments are directed to compounds of the formulae (I), (Ia), (Ib), (II), (IIa) (III), (IV), (V), and (VI); methods for treating cancer with one or more compounds of the formulae (I), (Ia), (Ib), (II), (IIa); (III), (IV), (V), and (VI); and methods for inhibiting a human topoisomerase with one or more compounds of the formulae (I), (Ia), (Ib), (II), (IIa); (III), (IV), (V), and (VI).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.